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While it is now well-established that resident populations of stem and progenitor cells
drive neurogenesis in the adult brain, a growing body of evidence indicates that these
new neurons play a pivotal role in spatial learning, memory, and mood regulation. As such,
interest is gathering to develop strategies to harness the brain’s endogenous reservoir of
stem and progenitor cells, with the view that newborn neurons may help overcome the
loss of neural and cognitive function that occurs during neurodegenerative disease and
psychiatric illness. Here we review evidence for the presence of endogenous stem cell
populations in the adult hippocampus, especially large pools of latent stem and precursor
cells, and the ways in which these populations can be stimulated to produce new neurons.
While the translation of this research from animal models to human application is still in
its infancy, understanding in detail the cellular and molecular mechanisms that regulate
endogenous neurogenesis, offers the potential to use this innate reservoir of precursors
to produce neurons that may be able to mitigate against cognitive decline and mood
disorders.
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INTRODUCTION
Stem cells have the remarkable ability to self-renew, divide and
differentiate into diverse cell types. We are starting to realize the
vast implications embryonic and adult stem cells may have for
regenerative medicine. In particular, there is a great degree of
interest in the development of strategies to harness the therapeu-
tic potential of endogenous neural stem cells in the adult brain for
their use in the treatment of neurological disorders. With precise
and controlled manipulation, stem cells may have the capacity to
replace damaged neurons, halt the progression of neurodegener-
ative diseases, and ultimately recover function in damaged area(s)
of the brain. Since 1992, it has been know that endogenous stem
and precursor cells reside in the brains of adult animals (Reynolds
and Weiss, 1992; Richards et al., 1992), primarily, though by no
means exclusively, in two major areas of the adult brain—the
subgranular zone (SGZ) of the hippocampus, and the subven-
tricular zone of the lateral ventricles—and have been shown to
continuously generate functional new neurons throughout adult-
hood. Furthermore, considering recent studies demonstrating the
crucial role of newborn neurons in learning and memory forma-
tion (Deng et al., 2010; Marin-Burgin and Schinder, 2012) and
mood regulation (Sahay andHen, 2007), the enhancement of hip-
pocampal neurogenesis has immense potential for the treatment
of age-associated cognitive decline, dementia, and mental health
disorders.
Adult hippocampal neurogenesis in the SGZ is a tightly orches-
trated process, involving the maintenance, activation and pro-
liferation of the stem cells; differentiation and migration of the
intermediate progenitors; and maturation of the newborn neu-
rons (Bergami and Berninger, 2012; Jhaveri et al., 2012; Lugert
et al., 2012). Following successful integration into the neuronal
network, these neurons are able to contribute to hippocampal
function, as well as sculpt the existing circuitry (Song et al., 2012).
A host of intrinsic and extrinsic factors regulates each of these
developmental stages (Zhao et al., 2008; Ming and Song, 2011;
Jhaveri et al., 2012). To exploit the brain’s endogenous reser-
voir of hippocampal neural stem cells as a potential therapeutic
strategy, it is necessary to examine (1) the properties of stem
cells that enable them to proliferate, and (2) the methods that
can be employed to stimulate their proliferation and neuronal
differentiation.
THE QUIESCENT POPULATION OF STEM AND PROGENITOR
CELLS IN THE ADULT HIPPOCAMPUS
As mentioned, a bona fide stem cell must have the defining char-
acteristics of self-renewal through mitotic division, and the ability
to differentiate into different cell types. On the other hand, if a
cell has limited self-renewal and restricted lineage potential, it is
classified as a progenitor cell (Bonaguidi et al., 2011). Without
specific techniques to distinguish between these two cell types,
stem and progenitor cells are often collectively referred to as
precursor cells. Nevertheless, with our advancing understand-
ing of the transcription factors and markers expressed during
the different stages of neurogenesis (Hodge and Hevner, 2011;
von Bohlen und Halbach, 2011), the introduction of constitu-
tive reporters and inducible transgenic mouse lines (Dhaliwal
and Lagace, 2011), and morphological criteria, successful iden-
tification of stem and progenitor cells is becoming somewhat
easier.
Nevertheless, because unequivocal identification of the poten-
tial of a single precursor in vivo is still very difficult, charac-
terization and enumeration of stem and progenitor cells in the
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hippocampus has largely arisen from in vitro studies utilizing
the neurosphere assay (Bull and Bartlett, 2005; Walker et al.,
2008; Jhaveri et al., 2010). When dissociated precursor cells from
adult hippocampal tissue are exposed to mitogens, such as epi-
dermal growth factor (EGF) and basic fibroblast growth factor
(bFGF), they proliferate to form a ball of cells called a neu-
rosphere. We have found the size of a neurosphere reflects the
proliferative capacity of the original precursor cell; for instance,
a stem cell with great proliferative and self-renewal potential
can generate a neurosphere over 250µm in diameter, whereas a
progenitor cell with limited self-replication generates a neuro-
sphere ∼50µm in diameter (Walker et al., 2008; Jhaveri et al.,
2010). Using this in vitro approach, our laboratory was the first
to report the presence of a large and previously unidentified
population of predominantly quiescent stem cells in the adult
mouse hippocampus (Walker et al., 2008). In this study, disso-
ciated hippocampal cells were cultured with depolarizing levels of
potassium chloride (KCl), which activated a quiescent population
of precursor cells to proliferate and produce a more than two-fold
increase in number of neurospheres compared to control con-
ditions. Furthermore, a small number (approximately eight per
hippocampus) of very large neurospheres (>250µm in diame-
ter) were obtained, which displayed the stem cell properties of
self-renewal and multipotentiality. When the active and rapidly
dividing precursor population (i.e., precursors that formed neu-
rospheres under non-depolarizing conditions) were ablated with
the anti-mitotic agent AraC (cytosine-b-D-arabinofuranoside),
the quiescent pool of precursor cells remained intact, and
responded to high KCl stimulation (Walker et al., 2008). Recently,
we have shown that stimulation with the monoaminergic neu-
rotransmitter, norepinephrine, directly activated another pop-
ulation of latent stem and precursor cells, via β3-adrenergic
receptors, in the adult hippocampus, which is quite distinct
from the KCl-activated population (Jhaveri et al., 2010). This
raises the tantalizing prospect that these distinct populations
may have give rise to subtly different populations of neuronal
progeny. Importantly, a recent in vivo clonal analysis, using
sparsely labeled and inducible Nestin-positive cells, confirmed the
existence of a small population—of similar size to that we iden-
tified in vitro—of quiescent stem cells in the hippocampus that
are also capable of self-renewal and multipotent differentiation
(Bonaguidi et al., 2011).
The existence of the quiescent stem cell population in the
hippocampus has important ramifications for the use of neuro-
genesis as a therapeutic strategy for functional recovery following
brain injury and disease. Given that stem cells in the quiescent
pool are usually dormant, and have a seemingly limitless capacity
for proliferation, this population offers an untapped resource for
the activation and augmentation of neurogenesis. Thus, the most
direct and robust method of increasing the rate of neurogenesis
will be to activate the quiescent stem cell pool; however, unless
self-renewal in the quiescent population is precisely maintained
by a number of factors, includingNotch signaling (Pierfelice et al.,
2011), its reservoir of stem cells may become depleted, leading
to the premature loss of neurogenesis. Furthermore, the mech-
anisms regulating neuronal differentiation, survival and integra-
tionmust also be well-managed to obtain successful neurogenesis.
In terms of origin, there may exist a reciprocal relationship
between the quiescent and active stem cells in the hippocampus,
in that they are able to give rise to one another (Suh et al., 2007;
Lavado et al., 2010). Nevertheless, while these two subpopula-
tions are kept in a delicate equilibrium by a number of factors,
the precise mechanisms underlying how these pools are regulated
and maintained, and the flux between their quiescent and active
states, requires further characterization. Nonetheless, we believe
that molecular signals may “prime” quiescent precursor cells to
be able to respond to proliferative signals coming from the hip-
pocampal niche (see Figure 1). Whether these signals come from
newborn neurons, mature granule cells or surrounding glial cells
as a result of neuronal activity is just beginning to be understood.
ACTIVATION OF THE QUIESCENT STEM CELL POPULATION
The SGZ of the hippocampus is enriched with a vast number
of projections arising from a number of areas throughout the
brain, which modulate neuronal activity in the dentate gyrus.
Neurotransmitters released from these projections have been
shown to affect multiple stages of hippocampal neurogenesis
(Vaidya et al., 2007). Furthermore, growth factors and signaling
molecules that are upregulated following high-intensity neu-
ronal activity may also modulate hippocampal neurogenesis (e.g.,
Balkowiec and Katz, 2002; Chen et al., 2006). For instance, envi-
ronmental novelty and neuronal activity-mediated activation of
noradrenergic terminals in the dentate gyrus have been shown to
result in the release of norepinephrine (Harley, 2007; King and
Williams, 2009; Neugebauer et al., 2009), which in turn has been
shown to directly activate the Hes5-expressing quiescent pool of
stem and precursor cells in the adult hippocampus (Jhaveri et al.,
2010). While there is a burgeoning number of putative candidates
that regulate neurogenesis, we focus here on the role of neuronal
activity in the activation of the quiescent stem cell pool in the
adult hippocampus.
ELECTROPHYSIOLOGICAL STIMULATION
Learning-related electrophysiological stimulation of the hip-
pocampus has been widely shown to promote precursor cell
proliferation and the survival of newborn neurons in the SGZ
(Bruel-Jungerman et al., 2006; Chun et al., 2006; Toda et al.,
2008; Kitamura et al., 2010; Stone et al., 2011; Kameda et al.,
2012). Nevertheless, the mechanisms underlying how the pre-
cursor population responds to the induction of LTP have not
yet been definitively revealed. We have shown recently that acti-
vation of the precursor cell population occurs only following
the successful induction of LTP in the dentate gyrus in vivo
(Kameda et al., 2012). These precursors appear to be the same
population that responds to KCl stimulation in vitro, as high
KCl did not further increase the number of neurospheres in
the LTP-induced hippocampal cells. The LTP-mediated activa-
tion of precursor cells, and the increase in the production of
doublecortin (DCX)-positive neurons observed in vivo, was spe-
cific to the induction of NMDA-dependent late-LTP, as this effect
was blocked by the NMDA receptor antagonist CPP [(6)-3-(2-
carboxypiperazin-4-yl)propyl-1-phosphonic acid], administered
shortly before the induction of LTP. Similarly, protocols that deliv-
ered low-frequency stimulation, or high-frequency stimulation
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FIGURE 1 | Activation of the endogenous population of quiescent stem
cells in the adult hippocampus as a therapeutic strategy for neural
injury and disease. Enhancement of neurogenesis, through activation of the
quiescent stem cell pool, may facilitate neuronal repair and recovery of
cognitive function following aging, neuronal disorders, psychiatric conditions,
and neurodegenerative diseases. For instance, neuronal activity, such as that
which occurs during learning, the induction of long-term potentiation (LTP)
and in vitro depolarization, potently activates quiescent stem cell
proliferation. A different subpopulation of stem cells is activated following
exposure to norepinephrine (NE), and it is thought that this population
responds to NE-mediated antidepressant treatment which can alleviate
clinical depression. Patterns of electrical stimulation, such as deep brain
stimulation and electroconvulsive shock, which are currently used to treat
many neurodegenerative and psychiatric conditions in human patients, have
also been shown to promote proliferation in animal models. Newborn
neurons arising from the distinct progenitor cell pools may have differential
roles in the functional outcome of neurodegenerative disease and psychiatric
illness. Abbreviations: NE, norepinephrine; LTP, long-term potentiation.
that failed to induce LTP or only induced early-LTP, did not affect
precursor activation or proliferation. Interestingly, the magnitude
of LTP strongly correlated with the extent of precursor cell activa-
tion, suggesting a dose-dependent-like mechanism underlies this
effect. While speculative, it is possible that LTP induction some-
how primes hippocampal precursor cells to respond to factors
that directly activate proliferation. This effect may be tempo-
rally transient, given that when the hippocampus was dissociated
4 days following the induction of LTP, no significant increase in
activation of precursor cells was seen in vitro (Kameda et al.,
2012). Nonetheless, these observations are the first to provide
direct evidence that patterns of synaptic activity associated with
learning and memory can activate latent precursor cells in the
adult hippocampus, as well as increase neuron production. More
studies are required to investigate the mechanism of precursor cell
activation following defined patterns of physiological stimulation,
considering that synaptic plasticity, learning, and neurogenesis
are intimately linked.
Other patterns of electrical stimulation have also been shown
promote neurogenesis. Stimulation protocols used to induce elec-
troconvulsive seizure (ECS) robustly increase the proliferation
and survival of progenitor cells in rodents (Madsen et al., 2000;
Ito et al., 2010) and non-human primates (Perera et al., 2007).
Furthermore, recent clinical advances are starting to show that
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deep brain stimulation (DBS) of the human brain can successfully
treat many psychiatric and neurological conditions (reviewed in
Cramer et al., 2011; Moreines et al., 2011; Hamani and Temel,
2012), and has been shown to affect neurogenesis in rodent
models of disease (e.g., Khaindrava et al., 2011). While the link
between electrical stimulation of the human brain and neu-
rogenesis awaits investigation, a phase I clinical trial assessing
the effect of DBS targeting the fornix/hypothalamus in patients
experiencing mild Alzheimer’s disease has revealed that some
patients showed a slower rate of cognitive decline over a 12-
month period (Laxton et al., 2010). Therefore, given the ability of
electrical stimulation to enhance endogenous neurogenesis, and
the strong links between neurogenesis in the SGZ and improve-
ment in cognitive function (e.g., Deng et al., 2010; Marin-Burgin
and Schinder, 2012), stimulating the quiescent population of
stem and precursor cells to augment endogenous neurogenesis
to recover or enhance cognitive function in neurodegenerative
disease in an alluring prospect. Nevertheless, the identity of the
latent precursor pool(s) that respond to the different patterns
of electrical activity (e.g., LTP-inducing high-frequency stimu-
lation, ECS and DBS) to generate new neurons remains to be
addressed.
HIPPOCAMPAL NEUROGENESIS AND AGING
It is now well-established that hippocampal neurogenesis dra-
matically decreases with age. Aged animals show significantly less
precursor and progenitor cell proliferation, neuronal differentia-
tion and newborn neuron survival (reviewed by Lee et al., 2012).
This is also true for the number of neurospheres that can be
generated from mice as they age, which by 18 months in the hip-
pocampus, declines by about 80% (Walker et al., 2008). The cause
of this neurogenic decline over time is not well-understood, as
many factors underlying the maintenance and regulation of neu-
rogenesis are altered in the aged brain (Artegiani and Calegari,
2012; Lee et al., 2012). Nonetheless, given the negative impact of
aging on hippocampal neurogenesis (Lee et al., 2012) and cogni-
tive function (e.g., Rosenzweig and Barnes, 2003), stimulating the
endogenous stem cell pool in the aged brainmay be able to restore
the memory and cognitive deficits observed in age-associated and
mild cognitive impairment, and neurodegenerative diseases, such
as Alzheimer’s disease (e.g., Laxton et al., 2010).
To develop an effective strategy to enhance neurogenesis in
the aged hippocampus, it is important to identify whether the
age-related reduction in proliferation and neurogenesis results
from an increase in stem cell quiescence over time (Lugert et al.,
2010; Bonaguidi et al., 2011), or depletion of the stem cell pool
(Encinas et al., 2011). A study from our laboratory has shown
that the aged brain does in fact retain a population of quiescent
stem cells, which have the capacity to respond to stimuli that acti-
vate proliferation in vitro (Walker et al., 2008). Indeed, physical
exercise, which strongly increases stem cell proliferation and neu-
ron production (van Praag et al., 1999; Kronenberg et al., 2003;
Lugert et al., 2010), has been positively correlated with improved
hippocampal-dependent cognitive performance in aged animals
(van Praag et al., 2005; Marlatt et al., 2012). While a number
of factors may underlie the neurogenic and cognitive restora-
tion observed in aged animals following physical exercise (see Lee
et al., 2012), a strong case has recently been made for the involve-
ment of growth hormone in this process in the subventricular
zone (SVZ) (Blackmore et al., 2009, 2012). Further investigation
is required to show whether growth hormone mediates exercise-
induced activation of the quiescent precursor cell population in
the aged hippocampus.
We have shown recently that microglia are also very important
in regulating the activation of precursors in the aging animal and
after exercise (Vukovic et al., 2012). Removal of microglia from
the hippocampal population in aged animals leads to a significant
increase in precursor activation, indicating the low number of
active precursors may be due to the inhibitory effects of microglia,
probably through the release of cytokines. Conversely, microglia
removed from hippocampal cultures of young animals has no
effect, but their removal following running decreases neurosphere
numbers, indicating microglia play a positive role in the acti-
vation process. We have shown that the ability of microglia to
increase precursor activity is due to the release of the chemokine,
CX3C (also known as fractalkine) from neurons, and that lev-
els of this ligand decrease dramatically with age (Vukovic et al.,
2012). These results open the possibility that raising CX3C lev-
els may increase neurogenesis in the aging animal. In addition,
we have found that interferon gamma, another cytokine found
normally in the hippocampus that is raised during inflamma-
tory conditions, is also a potent inhibitor of precursor activation.
Interestingly, this inhibition can be partially blocked by factors
released from microglia (Li et al., 2010). This environment of
negative and positive regulators of hippocampal precursor acti-
vation poses some challenges, especially in the aged animal, as
we try to stimulate the appropriate neurogenic production in the
hippocampus in a way that leads to the enhancement of func-
tion in the aged brain suffering cognitive decline, as outlined
in Figure 1.
HIPPOCAMPAL NEUROGENESIS IN MOOD-RELATED
DISORDERS
Another area of research in which hippocampal neurogenesis has
received considerable attention is in the investigation of animal
models of depression, and specifically, the mechanisms underly-
ing the actions of antidepressants (reviewed by Sahay and Hen,
2007). Changes in hippocampal neurogenesis have now been
implicated in the etiology of depression; furthermore, current
antidepressant treatments are thought to target these neurogenic
changes (Santarelli et al., 2003; David et al., 2009; Snyder et al.,
2011; Surget et al., 2011). Given the Australian National Survey of
Mental Health and Wellbeing (2007) reported that about 20% of
the population experience some form of mental disorder within
a 12-month period, with mood-related disorders such as anxiety
and depression being the most prevalent, a thorough understand-
ing of the cellular and molecular mechanisms underlying these
conditions is necessary to be able to identify novel therapeutic
strategies.
Studies have shown an enhancement of hippocampal neu-
rogenesis following chronic treatment with clinical antidepres-
sants (Malberg et al., 2000; Duman, 2004; Perera et al., 2007).
In particular, ECS, which initiate rapid onset of antidepres-
sant action, have been shown to increase the proliferation
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of GFAP- and Sox2-positive quiescent stem cells in the SGZ
(Segi-Nishida et al., 2008). More recently, we have shown that
norepinephrine, and antidepressants that block the reuptake
of norepinephrine (such as reboxetine and atomoxetine), also
increase proliferation by directly activating the quiescent popu-
lation of precursors in the hippocampus (Jhaveri et al., 2010).
In fact, the neurogenesis-depression hypothesis proposes that
the functional effect of antidepressant treatment is mediated
by the addition of new neurons to the hippocampal network
(Kempermann and Kronenberg, 2003). This hypothesis is sup-
ported by the strong correlation that exists between the time-
line of new neuron production and the delayed onset of the
beneficial effects of antidepressant medication (Nestler et al.,
2002; Sahay and Hen, 2007). Importantly, the blockade of hip-
pocampal neurogenesis has been shown to inhibit some, but not
all, of the therapeutic-like effects of antidepressants in rodent
models (Santarelli et al., 2003; David et al., 2009); however,
no anxiety/depressive-like behavior has been observed in ani-
mals lacking neurogenesis, suggesting impairment in neurogen-
esis alone is not sufficient to cause mood-related disorders. To
better understand the etiology of depression, a detailed under-
standing of the interactions between the hippocampus and other
brain areas is needed, with an emphasis on the precise molecu-
lar mechanisms by which newborn neurons in the hippocampus
ameliorate depression.
The hippocampus is known to play an important role in reg-
ulating stress through the hypothalamic-pituitary-adrenal (HPA)
axis (Herman et al., 1989; Mizoguchi et al., 2003). While several
studies have shown that chronic stress or an elevation of cor-
tisol levels decreases neurogenesis (Gould et al., 1998; Murray
et al., 2008; Lagace et al., 2010), two recent studies have sug-
gested that newborn hippocampal neurons mediate the feedback
inhibition of the HPA axis following stress, thereby regulating
blood cortisol levels (Snyder et al., 2011; Surget et al., 2011).
Snyder and colleagues (2011) have shown that in animals in
which neurogenesis has been ablated, restraint stress leads to a
longer-lasting elevation in cortisol levels compared to animals
with intact neurogenesis. In addition, neurogenesis-ablated mice
show increased food avoidance in a novel environment, indicat-
ing higher levels of anxiety. Importantly, Surget and colleagues
(2011) have shown that fluoxetine treatment, in the absence of
ongoing neurogenesis, fails to restore HPA axis activity and func-
tion in neurogenesis-ablated animals subjected to unpredictable
chronic stress.
Taken together, it appears that functional hippocampal neu-
rogenesis plays an important role in preventing the onset of
mood-related disorders following chronic stress, and importantly,
acts as a substrate for the therapeutic action of antidepressants.
Enhancing the production of newborn neurons by harnessing the
potential of endogenous precursor populations may therefore be
an extremely useful therapeutic approach (see Figure 1). Given
that at least two large latent precursor populations have been
uncovered so far in the hippocampus (Walker et al., 2008; Jhaveri
et al., 2010), driving neuronal production by enhancing the pro-
liferative activity could indeed boost hippocampal neurogenesis.
While the monoaminergic family of drugs remain the front line
choice for the treatment of mood disorders, their ineffectiveness
and distressing side effects warrants the discovery of new antide-
pressant treatments (Ellis, 2004). More effective, rapid-acting
and long-lasting antidepressants may emerge from undertaking
a detailed molecular characterization of these latent precursor
pools, as well their neuronal progeny, which may lead to the iden-
tification of novel targets for drug development (Jhaveri et al.,
2012). Finally, enhancing neuronal production may also prove
beneficial for neurodegenerative diseases that involve significant
cellular and functional loss in the hippocampus.
CONCLUSIONS
Resident populations of endogenous stem and progenitor cells
drive the production of new neurons in the adult hippocam-
pus. These precursor pools are carefully regulated and precisely
maintained, such that upon pathological insult or homeostatic
perturbations, proliferation can be rapidly enhanced to replace
neurons lost due to damage or dysfunction. Nevertheless, enhanc-
ing proliferation alone is often not enough to generate sufficient
numbers of new neurons and restore normal function. As such,
various methods of further activating and amplifying stem and
progenitor cells in the hippocampus have provided some posi-
tive results for the recovery of hippocampal-dependent behavioral
functions in animal models.
While we have discussed the stimulation of endogenous neu-
ral stem cells in a number of disease states in rodent models,
effective therapies for human application must be tailored to
the endogenous microenvironment of the human neurogenic
niche. Currently, there are limited studies providing evidence for
ongoing hippocampal neurogenesis in the adult human brain
(Eriksson et al., 1998; Blumcke et al., 2001; Sanai et al., 2004);
furthermore, the cell cycle length in primates appears to be sub-
stantially longer than in rodents, indicating a much slower rate
of proliferation and precursor cell turnover (Breunig et al., 2011;
Curtis et al., 2012). Additional research is therefore required to
examine the extent of adult neurogenesis in the human brain, for
instance, using post-mortem brain tissue from age-matched con-
trols, as well as patients suffering from mood and neurological
disorders. Given that post-mortem brain tissue can only provide
a temporal snapshot of neurogenesis, advances in live imaging
techniques that can track cell proliferation in the human hip-
pocampus at high resolution will open an exciting avenue for
future investigation. In addition, the development of sophisti-
cated drug delivery technology is needed to specifically target
and activate proliferation of the endogenous populations of stem
cells, and to facilitate the differentiation, migration, integration,
and survival of newborn neurons. Nevertheless, a detailed under-
standing of the fundamental mechanisms regulating neurogenesis
in animal models will be crucial in order to utilize the endoge-
nous stem cell populations as a therapeutic approach in patients
suffering from brain injury and disease.
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